AstraZeneca’s IMFINZI (durvalumab) has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tract cancer (BTC)...
Avacta Group plc, a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer and pre|CISION™ platforms, announces that...
SLINGSHOT BIOSCIENCES, INC., the makers of synthetic control cells for cell analysis applications, including flow cytometry, enabling precise, reliable, and repeatable results, today announced...
Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced the release of an abstract by ESMO with preliminary results from the company’s Phase...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine has been...
